# | Title | Journal | Year | Citations |
---|
1 | Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients | Obesity Medicine | 2020 | 130 |
2 | “Covibesity,” a new pandemic | Obesity Medicine | 2020 | 123 |
3 | Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection | Obesity Medicine | 2020 | 98 |
4 | The mutual effects of COVID-19 and obesity | Obesity Medicine | 2020 | 68 |
5 | Exercise against SARS-CoV-2 (COVID-19): Does workout intensity matter? (A mini review of some indirect evidence related to obesity) | Obesity Medicine | 2020 | 65 |
6 | Obesity risk during collective quarantine for the COVID-19 epidemic | Obesity Medicine | 2020 | 64 |
7 | Diabetes in Ethiopia: A systematic review of prevalence, risk factors, complications, and cost | Obesity Medicine | 2019 | 54 |
8 | Dietary habits in adults during quarantine in the context of COVID-19 pandemic | Obesity Medicine | 2020 | 53 |
9 | COVID-19: How the quarantine could lead to the depreobesity | Obesity Medicine | 2020 | 46 |
10 | Metformin: A review of its therapeutic efficacy and adverse effects | Obesity Medicine | 2020 | 44 |
11 | Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity | Obesity Medicine | 2020 | 39 |
12 | Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity | Obesity Medicine | 2020 | 37 |
13 | Obesity and food addiction: Similarities to drug addiction | Obesity Medicine | 2019 | 35 |
14 | Current status on obesity in childhood and adolescence: Prevalence, etiology, co-morbidities and management | Obesity Medicine | 2016 | 34 |
15 | A novel hybrid approach for diagnosing diabetes mellitus using farthest first and support vector machine algorithms | Obesity Medicine | 2020 | 34 |
16 | Prevalence of anxiety and depression in patients with overweight and obesity | Obesity Medicine | 2020 | 34 |
17 | Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A randomised controlled trial | Obesity Medicine | 2020 | 34 |
18 | Fast food consumption and obesity among urban college going adolescents in Bangladesh: A cross-sectional study | Obesity Medicine | 2020 | 33 |
19 | Association of overweight and obesity with obstructive sleep apnoea: A systematic review and meta-analysis | Obesity Medicine | 2020 | 33 |
20 | Hypoxia-inducible factor (HIF): The link between obesity and COVID-19 | Obesity Medicine | 2021 | 32 |
21 | Relationship between overweight/obesity and mental health disorders among Bangladeshi adolescents: A cross-sectional survey | Obesity Medicine | 2020 | 31 |
22 | Junk food-induced obesity- a growing threat to youngsters during the pandemic | Obesity Medicine | 2021 | 31 |
23 | A review of phytochemistry and pharmacology profile of Juglans regia | Obesity Medicine | 2019 | 30 |
24 | Understanding antagonism and synergism: A qualitative assessment of weight management in youth with Type 1 diabetes mellitus | Obesity Medicine | 2018 | 29 |
25 | Effect of swimming training on levels of asprosin, lipid profile, glucose and insulin resistance in rats with metabolic syndrome | Obesity Medicine | 2019 | 29 |
26 | Ground flaxseed increased nitric oxide levels in adults with type 2 diabetes: A randomized comparative effectiveness study of supplemental flaxseed and psyllium fiber | Obesity Medicine | 2017 | 28 |
27 | ‘Nudge’ interventions for improving children's dietary behaviors in the home: A systematic review | Obesity Medicine | 2017 | 28 |
28 | The relationship between obesity and other medical comorbidities | Obesity Medicine | 2020 | 26 |
29 | A Zno nanorods based enzymatic glucose biosensor by immobilization of glucose oxidase on a chitosan film | Obesity Medicine | 2020 | 26 |
30 | A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection | Obesity Medicine | 2020 | 25 |
31 | Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment | Obesity Medicine | 2021 | 23 |
32 | Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect | Obesity Medicine | 2021 | 23 |
33 | Micronutrient status in obese patients: A narrative review | Obesity Medicine | 2020 | 22 |
34 | Effect of exercise training type on plasma levels of vaspin, nesfatin-1, and high-sensitivity C-reactive protein in overweight and obese women | Obesity Medicine | 2019 | 21 |
35 | Effect of daily probiotic yogurt consumption on inflammation: A systematic review and meta-analysis of randomized Controlled Clinical trials | Obesity Medicine | 2020 | 21 |
36 | Impact of the COVID-19 lockdown on weight status and associated factors for obesity among children in Massachusetts | Obesity Medicine | 2021 | 21 |
37 | Does higher body mass index increase COVID-19 severity? A systematic review and meta-analysis | Obesity Medicine | 2021 | 21 |
38 | Acute and chronic responses of metabolic myokine to different intensities of exercise in sedentary young women | Obesity Medicine | 2016 | 19 |
39 | Nuts effects in chronic disease and relationship between walnuts and satiety: Review on the available evidence | Obesity Medicine | 2020 | 19 |
40 | Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in Chinese overweight/obese PCOS women | Obesity Medicine | 2017 | 18 |
41 | Neuropathic pain in diabetes mellitus: Challenges and future trends | Obesity Medicine | 2020 | 18 |
42 | A community perspective of COVID-19 and obesity in children: Causes and consequences | Obesity Medicine | 2021 | 18 |
43 | Food industry self-regulation scheme “EU Pledge” cannot prevent the marketing of unhealthy foods to children | Obesity Medicine | 2016 | 17 |
44 | High intensity interval exercise enhances the global HDAC activity in PBMC and anti-inflammatory cytokines of overweight-obese subjects | Obesity Medicine | 2016 | 16 |
45 | Body Mass Index and risk of frailty in older adults: A systematic review and meta-analysis | Obesity Medicine | 2020 | 16 |
46 | The role of comorbidities on mortality of COVID-19 in patients with diabetes | Obesity Medicine | 2021 | 16 |
47 | Role of brain derived neurotropic factor in obesity | Obesity Medicine | 2020 | 16 |
48 | Factors affecting obesity and its treatment | Obesity Medicine | 2019 | 15 |
49 | Nutraceuticals in the management of obesity | Obesity Medicine | 2020 | 15 |
50 | Medical management of obesity in Scandinavia 2016 | Obesity Medicine | 2016 | 14 |